» Articles » PMID: 37635240

SIgA in Various Pulmonary Diseases

Overview
Journal Eur J Med Res
Publisher Biomed Central
Specialty General Medicine
Date 2023 Aug 27
PMID 37635240
Authors
Affiliations
Soon will be listed here.
Abstract

Secretory immunoglobulin A (SIgA) is one of the most abundant immunoglobulin subtypes among mucosa, which plays an indispensable role in the first-line protection against invading pathogens and antigens. Therefore, the role of respiratory SIgA in respiratory mucosal immune diseases has attracted more and more attention. Although the role of SIgA in intestinal mucosal immunity has been widely studied, the cell types responsible for SIgA and the interactions between cells are still unclear. Here, we conducted a wide search of relevant studies and sorted out the relationship between SIgA and some pulmonary diseases (COPD, asthma, tuberculosis, idiopathic pulmonary fibrosis, COVID-19, lung cancer), which found SIgA is involved in the pathogenesis and progression of various lung diseases, intending to provide new ideas for the prevention, diagnosis, and treatment of related lung diseases.

Citing Articles

Immunological Insights and Therapeutic Advances in COPD: Exploring Oral Bacterial Vaccines for Immune Modulation and Clinical Improvement.

Lewicki S, Balan B, Stelmasiak M, Radomska-Lesniewska D, Szymanski L, Rios-Turek N Vaccines (Basel). 2025; 13(2).

PMID: 40006655 PMC: 11861055. DOI: 10.3390/vaccines13020107.


Genetic diversity of the immunoglobulin heavy chain locus in cohorts of patients affected with SARS-CoV-2.

Malaspina P, Jodice C, Ciminelli B, Biancolella M, Colona V, Latini A Hum Genomics. 2025; 19(1):7.

PMID: 39885568 PMC: 11780896. DOI: 10.1186/s40246-025-00719-8.


Comprehensive analyses of immune activity in COVID-19-vaccinated idiopathic pulmonary fibrosis patients.

Maciejewska A, Czernia P, Piotrowska-Mieczkowska M, Wajda B, Slominski B, Romantowski J Front Immunol. 2025; 15():1436491.

PMID: 39845961 PMC: 11750670. DOI: 10.3389/fimmu.2024.1436491.


The role and mechanism of gut-lung axis mediated bidirectional communication in the occurrence and development of chronic obstructive pulmonary disease.

Song X, Dou X, Chang J, Zeng X, Xu Q, Xu C Gut Microbes. 2024; 16(1):2414805.

PMID: 39446051 PMC: 11509012. DOI: 10.1080/19490976.2024.2414805.


Gut microbiota dysbiosis and its impact on asthma and other lung diseases: potential therapeutic approaches.

Kim Y, Sohn K, Kang H Korean J Intern Med. 2024; 39(5):746-758.

PMID: 39252487 PMC: 11384250. DOI: 10.3904/kjim.2023.451.


References
1.
De Fays C, Carlier F, Gohy S, Pilette C . Secretory Immunoglobulin A Immunity in Chronic Obstructive Respiratory Diseases. Cells. 2022; 11(8). PMC: 9027823. DOI: 10.3390/cells11081324. View

2.
Li Y, Jin L, Chen T . The Effects of Secretory IgA in the Mucosal Immune System. Biomed Res Int. 2020; 2020:2032057. PMC: 6970489. DOI: 10.1155/2020/2032057. View

3.
Kaetzel C, Mestecky J, Johansen F . Two Cells, One Antibody: The Discovery of the Cellular Origins and Transport of Secretory IgA. J Immunol. 2017; 198(5):1765-1767. DOI: 10.4049/jimmunol.1700025. View

4.
Johansen F, Kaetzel C . Regulation of the polymeric immunoglobulin receptor and IgA transport: new advances in environmental factors that stimulate pIgR expression and its role in mucosal immunity. Mucosal Immunol. 2011; 4(6):598-602. PMC: 3196803. DOI: 10.1038/mi.2011.37. View

5.
Rees F, Doherty M, Grainge M, Lanyon P, Zhang W . The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies. Rheumatology (Oxford). 2017; 56(11):1945-1961. DOI: 10.1093/rheumatology/kex260. View